LivaNova (LIVN) Income from Continuing Operations (2014 - 2026)
LivaNova recorded quarterly Income from Continuing Operations of 23145000.0 in Q1 2026, down 25.14% quarter-over-quarter from 30916000.0 in Q4 2025, and up 107.07% year-over-year from 11177301.32 in Q1 2025.
LivaNova's Income from Continuing Operations history runs 13 years deep, the most recent figure standing at 23145000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 107.07% year-over-year to 23145000.0; the TTM figure through Mar 2026 stood at 108027000.0 (up 148.63% YoY), while the FY2025 annual figure was 242420000.0, down 483.26% from the prior year.
- Income from Continuing Operations came in at 23145000.0 for Q1 2026 at LivaNova, down from 30916000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 55891000.0 in Q4 2024 to a low of 327302000.0 in Q1 2025.
- A 5-year average of 13209764.71 and a median of 16356000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations soared 1283.09% in 2024 and sank 680.83% in 2025, its largest moves.
- LivaNova's Income from Continuing Operations stood at 1690000.0 in 2022, then soared by 867.81% to 16356000.0 in 2023, then soared by 241.72% to 55891000.0 in 2024, then plunged by 44.69% to 30916000.0 in 2025, then retreated by 25.14% to 23145000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 23145000.0, 30916000.0, and 26797000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 23.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.15 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 27.17 Mn |
| Mar 31, 2025 | -327.30 Mn |
| Dec 31, 2024 | 55.89 Mn |
| Sep 30, 2024 | 32.92 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | -41.92 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | -107.40 Mn |
| Jun 30, 2022 | 16.49 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | -5.09 Mn |
| Sep 30, 2021 | -43.42 Mn |
| Jun 30, 2021 | -56.45 Mn |
| Mar 31, 2021 | -30.72 Mn |
| Dec 31, 2020 | -283.10 Mn |
| Sep 30, 2020 | -14.72 Mn |
| Jun 30, 2020 | -87.95 Mn |
| Mar 31, 2020 | 38.71 Mn |
| Dec 31, 2019 | -145.88 Mn |
| Sep 30, 2019 | 32.12 Mn |
| Jun 30, 2019 | -29.39 Mn |
| Mar 31, 2019 | -14.85 Mn |
| Dec 31, 2018 | -209.52 Mn |
| Sep 30, 2018 | -6.27 Mn |
| Jun 30, 2018 | 19.79 Mn |
| Mar 31, 2018 | 18.18 Mn |
| Dec 31, 2017 | -31.24 Mn |
| Sep 30, 2017 | 27.42 Mn |
| Jun 30, 2017 | 59.78 Mn |
| Mar 31, 2017 | 15.18 Mn |
| Dec 31, 2016 | 34.16 Mn |
| Sep 30, 2016 | 11.56 Mn |
| Jun 30, 2016 | 12.49 Mn |
| Mar 31, 2016 | -37.66 Mn |
| Oct 18, 2015 | -25.09 Mn |
| Jul 24, 2015 | 12.42 Mn |
| Apr 24, 2015 | 10.51 Mn |
| Dec 26, 2014 | 4.28 Mn |
| Oct 24, 2014 | 17.27 Mn |
| Apr 25, 2014 | 66.48 Mn |